A Study to evaluate the therapeutic effectiveness of selective Siddha Medicines – VeBSaM Therapy in the management of Cholelithiasis

An Open clinical trial to evaluate the therapeutic effectiveness of selective Siddha Medicines - VeBSaM Therapy in the management of Cholelithiasis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069131

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Vengara parpam, Bavana panjangula thailam, Santha santhrothayam, Manjal noi kudineer: Vengara Parpam - 100 mg Bd With Ghee, Bavana Panjangula Thailam - 4 ml Bd With Milk, Santha Santhr

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants who were diagnosed Cholelithiasis by ultrasound scanning – size of the gallbladder stone between 3 to 10 mm.

Exclusion criteria

Exclusion criteria: 1.Participants with comorbidities like renal failure and liver cirrhosis 2.Pregnant and lactating mother. 3.Severe Cholecystitis, Choledocholithiasis, Acute and Chronic Pancreatitis. 4.Participants with Gallstone present in neck of gall bladder.

Design outcomes

Primary

Measure	Time frame
Reduction in the size of stone will be assessed by ultra sonogram before and after treatmentTimepoint: 6 MONTHS	—

Secondary

Measure	Time frame
Scoring Difference will be assessed in OTAGO Gallstones condition specific questionnaire in cholelithiasis participants before and after taking siddha treatmentTimepoint: 6 MONTHS	—

Countries

India

Contacts

Public ContactDr T LAKSHMIKANTHAM

National Institute of Siddha

drlakshmiramaswamy@gmail.com9025575185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026